CVS:NYE-CVS Health Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 61.54

Change

-1.34 (-2.13)%

Market Cap

N/A

Volume

0.02B

Analyst Target

USD 78.78
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

-1.38 (-0.24%)

USD 530.79B
ELV Elevance Health Inc

-8.74 (-1.68%)

USD 121.50B
CNC Centene Corp

-1.34 (-1.78%)

USD 38.77B
MOH Molina Healthcare Inc

-2.65 (-0.77%)

USD 19.84B
OSCR Oscar Health Inc

-0.58 (-2.73%)

USD 5.25B
NEUE NeueHealth Inc

+0.07 (+1.31%)

USD 0.05B
CI Cigna Corp

+1.65 (+0.48%)

N/A
HUM Humana Inc

-37.29 (-11.77%)

N/A

ETFs Containing CVS

WBIY WBI Power Factor® High D.. 4.72 % 0.70 %

-0.17 (0.00%)

USD 0.06B
UNCU:LSE First Trust US Equity Inc.. 2.97 % 0.00 %

-0.21 (0.00%)

USD 0.04B
UINC:LSE First Trust US Equity Inc.. 2.88 % 0.00 %

+14.50 (+0.00%)

USD 0.31B
LUSC:LSE SPDR Barclays 10+ U.S. Co.. 0.43 % 0.00 %

+0.15 (+0.00%)

N/A
LCRP:LSE SPDR Barclays 10+ U.S. Co.. 0.42 % 0.00 %

+0.30 (+0.00%)

USD 0.09B
SUSC:LSE SPDR Barclays 0-3 Year US.. 0.41 % 0.00 %

+0.02 (+0.00%)

N/A
SYBN:F SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

N/A

USD 0.10B
SYBN:XETRA SPDR Barclays 10+ U.S. Co.. 0.37 % 0.00 %

+0.30 (+0.00%)

USD 0.10B
SYBR:F SSgA SPDR ETFs Europe I P.. 0.30 % 0.00 %

+0.30 (+0.00%)

USD 0.23B
SYBR:XETRA SPDR Barclays 3-10 U.S. C.. 0.30 % 0.00 %

+0.23 (+0.00%)

USD 0.23B
IUCB:SW SPDR® Bloomberg 1-10 Yea.. 0.30 % 0.00 %

N/A

USD 0.31B
AGGY WisdomTree Yield Enhanced.. 0.00 % 0.12 %

+0.19 (+0.00%)

USD 0.99B
BSCP Invesco BulletShares 2025.. 0.00 % 0.10 %

+0.01 (+0.00%)

N/A
ESGF 0.00 % 0.40 %

N/A

N/A
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.08B
IBDL 0.00 % 0.10 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

-0.93 (0.00%)

N/A
ILTB iShares Core 10+ Year USD.. 0.00 % 0.06 %

+0.04 (+0.00%)

USD 0.65B
LQD iShares iBoxx $ Investmen.. 0.00 % 0.15 %

+0.13 (+0.00%)

N/A
SPLB SPDR Barclays Long Term C.. 0.00 % 0.08 %

+0.06 (+0.00%)

USD 1.02B
IG Principal Exchange-Traded.. 0.00 % 0.26 %

-0.01 (0.00%)

USD 0.09B
IGLB iShares 10+ Year Investme.. 0.00 % 0.10 %

+0.13 (+0.00%)

USD 2.87B
IBDT iShares iBonds Dec 2028 T.. 0.00 % 0.10 %

-0.05 (0.00%)

USD 2.24B
RTH VanEck Retail ETF 0.00 % 0.35 %

+0.18 (+0.00%)

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

-0.20 (0.00%)

N/A
SLQD iShares 0-5 Year Investme.. 0.00 % 0.06 %

-0.13 (0.00%)

USD 2.12B
SPVU Invesco S&P 500® Enhance.. 0.00 % 0.16 %

-0.24 (0.00%)

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

-0.49 (0.00%)

N/A
ICAN 0.00 % 0.50 %

N/A

N/A
UC84:LSE UBS Barclays US Liquid Co.. 0.00 % 0.00 %

+15.00 (+0.00%)

USD 0.09B
VVAL:LSE 0.00 % 0.00 %

N/A

N/A
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
GBLO 0.00 % 0.00 %

N/A

N/A
NVQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -22.06% 25% F 9% A-
Dividend Return 2.53% 100% F 45% F
Total Return -19.54% 25% F 9% A-
Trailing 12 Months  
Capital Gain -11.13% 25% F 11% F
Dividend Return 3.75% 100% F 49% F
Total Return -7.38% 25% F 12% F
Trailing 5 Years  
Capital Gain 0.52% 17% F 44% F
Dividend Return 18.16% 100% F 62% D
Total Return 18.68% 33% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain 3.20% N/A N/A 50% F
Dividend Return 5.99% N/A N/A 50% F
Total Return 2.78% N/A N/A 57% F
Risk Return Profile  
Volatility (Standard Deviation) 26.30% N/A N/A 39% F
Risk Adjusted Return 22.76% N/A N/A 41% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector